SHANNON MCLEAN: Open Payments
NPI 1730244880 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 51 payments from 30 companies in 2025. Trend: 2023 $19 · 2024 $534 · 2025 $1,258
Food & beverage: $1,189Education: $68
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $198 |
| E.R. Squibb & Sons, L.L.C. | 2 | $153 |
| PFIZER INC. | 7 | $135 |
| AstraZeneca Pharmaceuticals LP | 2 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Janssen Biotech, Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Celgene Corporation | 1 | $30 |
Products named: REBLOZYL, EPKINLY, IMFINZI, VENCLEXTA, FRUZAQLA, IBRANCE, OJJAARA, PADCEV.
Industry payments across AZ — which companies pay providers there.
